Sustainability

As one of the leading manufacturers of medicines in Australia, we have a responsibility to demonstrate our commitment to preserving our natural environment.

In 2010, we received a 10-year Green Globe sustainability certificate from the New South Wales Government. In 2011 we were recognised as a bronze member in the New South Wales Government’s Sustainability Advantage program. Our manufacturing facility was also recognised by the New South Wales Minister for Environment, Climate Change and Water, as winner of the 10 year Sustainability Achievement Award for outstanding long-term commitment to environment excellence.

We take very seriously our commitment to patient safety. We work continuously to identify and minimise the risks and maximise the benefits of each of our medicines – starting with the discovery of a potential new medicine and continuing throughout its development, launch and marketing.

During the development phase, extensive and rigorous pre-clinical and clinical testing is done to establish a potential new medicine’s safety and efficacy. After launch, we continue to monitor the use of all our medicines for any side effects not identified during the development process.

A vital aspect of our commitment to patient safety is making sure that accurate and up-to-date information is provided to support effective use of our medicines.

At AstraZeneca, we want to be valued for the medicines we provide and trusted for the way we work, so ethical business practices and integrity underpin everything we do. Our Code of Conduct sets out our core commitments and the high ethical standards expected of everyone at AstraZeneca as we drive our business forward.

We are committed to delivering consistently high ethical standards of sales and marketing practices worldwide and to working with only those third parties who embrace standards of ethical behaviour that are consistent with our own. We also aim to make a positive contribution to our local communities, wherever we are located in the world.

Society depends on us to conduct effective, ethical and thorough research in the development of our medicines and treatments.

We set high standards of ethical practice across all aspects of our research activity worldwide, from clinical trials to research with animals.